Does METOPROLOL Cause Tumour marker increased? 11 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Tumour marker increased have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.0% of all adverse event reports for METOPROLOL.
11
Reports of Tumour marker increased with METOPROLOL
0.0%
of all METOPROLOL reports
0
Deaths
7
Hospitalizations
How Dangerous Is Tumour marker increased From METOPROLOL?
Of the 11 reports, 7 (63.6%) required hospitalization, and 1 (9.1%) were considered life-threatening.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does METOPROLOL Cause?
Drug ineffective (3,434)
Dyspnoea (3,428)
Dizziness (3,275)
Hypotension (3,213)
Completed suicide (2,959)
Fatigue (2,784)
Off label use (2,580)
Toxicity to various agents (2,404)
Bradycardia (2,024)
Nausea (1,894)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
Which METOPROLOL Alternatives Have Lower Tumour marker increased Risk?
METOPROLOL vs METRELEPTIN
METOPROLOL vs METRONIDAZOLE
METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE
METOPROLOL vs METYRAPONE
METOPROLOL vs MEXILETINE